{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:31:05Z","timestamp":1791549065867,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s12072-022-10400-0","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T16:04:36Z","timestamp":1666109076000},"page":"1273-1281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["New progress towards elimination of mother-to-child transmission of hepatitis B virus in China"],"prefix":"10.1007","volume":"16","author":[{"given":"Hui","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olufunmilayo","family":"Lesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,18]]},"reference":[{"key":"10400_CR1","unstructured":"WHO. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Geneva: World Health Organization; 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240027077. Accessed Dec 18, 2021."},{"key":"10400_CR2","unstructured":"WHO. Global Health Sector Strategy on Viral hepatitis, 2016\u20132021. May 17, 2016. https:\/\/www.who.int\/publications\/i\/item\/WHO-HIV-2016.06. Accessed May 18, 2021."},{"key":"10400_CR3","unstructured":"WHO Regional Office for the Western Pacific. Regional Framework for the triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis in Asia and the Pacific 2018\u20132030. Aug 9, 2018. https:\/\/www.who.int\/publications\/i\/item\/9789290618553. Accessed May 18, 2021."},{"key":"10400_CR4","unstructured":"Ministry of Health, Chinese Center for Disease Control and Prevention. The National Report of Hepatitis B Sero-survey in China. Beijing: People\u2019s Medical Publishing House; 2010."},{"key":"10400_CR5","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1186\/s12889-019-7061-1","volume":"19","author":"H Zheng","year":"2019","unstructured":"Zheng H, Zhang G, Wang F, et al. Self-motivated medical care-seeking behaviors and disease progression in a community-based cohort of chronic hepatitis B virus-infected patients in China. BMC Public Health. 2019;19:901","journal-title":"BMC Public Health"},{"key":"10400_CR6","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3201\/eid2305.161477","volume":"23","author":"F Cui","year":"2017","unstructured":"Cui F, Shen L, Li L, et al. Prevention of chronic hepatitis b after 3 decades of escalating vaccination policy, China. Emerg Inf Dis. 2017;23:765\u2013772","journal-title":"Emerg Inf Dis"},{"key":"10400_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115\u2013132","journal-title":"CA Cancer J Clin"},{"key":"10400_CR8","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1001\/archpedi.161.12.1176","volume":"161","author":"Y Mikaeloff","year":"2007","unstructured":"Mikaeloff Y, Caridade G, Rossier M, et al. Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis. Arch Pediatr Adolesc Med. 2007;161:1176\u20131182","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10400_CR9","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S1473-3099(15)00158-9","volume":"15","author":"CL Thio","year":"2015","unstructured":"Thio CL, Guo N, Xie C, et al. Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy. Lancet Infect Dis. 2015;15:981\u2013985","journal-title":"Lancet Infect Dis"},{"key":"10400_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1136\/gutjnl-2015-310317","volume":"65","author":"M Ngu","year":"2016","unstructured":"Ngu M, Hardikar W, Cowie B, et al. Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders. Gut. 2016;65:340\u2013350","journal-title":"Gut"},{"key":"10400_CR11","first-page":"248","volume":"26","author":"R Aggarwal","year":"2007","unstructured":"Aggarwal R, Balachandran A, Menon U, et al. Reactogenicity of a combined hepatitis A and hepatitis B vaccine in healthy Indian children and adults. Indian J Gastroenterol. 2007;26:248\u2013249","journal-title":"Indian J Gastroenterol"},{"key":"10400_CR12","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1093\/ije\/dyy242","volume":"47","author":"F Cui","year":"2018","unstructured":"Cui F, Xu F. Response to: Antiviral treatment in pregnant women with chronic hepatitis B infection. Int J Epidemiol. 2018;47:2095\u20132096","journal-title":"Int J Epidemiol"},{"key":"10400_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/jvh.12757","volume":"25","author":"H Zheng","year":"2018","unstructured":"Zheng H, Cui FQ, Wang FZ, et al. The epidemiology of hepatitis B virus infection in women of reproductive age in highly endemic areas in China. J Viral Hepat. 2018;25:88\u201396","journal-title":"J Viral Hepat"},{"key":"10400_CR14","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/ije\/dyy077","volume":"47","author":"F Cui","year":"2018","unstructured":"Cui F, Woodring J, Chan P, et al. Considerations of antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus in China. Int J Epidemiol. 2018;47:1529\u20131537","journal-title":"Int J Epidemiol"},{"key":"10400_CR15","unstructured":"WHO. Interim guidance for country validation of viral hepatitis elimination. Geneva: World Health Organization; 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240028395. Accessed Jan 18, 2022"},{"key":"10400_CR16","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/01.PHH.0000296134.70014.b0","volume":"13","author":"H Groom","year":"2007","unstructured":"Groom H, Kolasa M, Wooten K, et al. Childhood immunization coverage by provider type. J Public Health Manage Pract. 2007;13:584\u2013589","journal-title":"J Public Health Manage Pract"},{"key":"10400_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2471\/BLT.18.219469","volume":"97","author":"J Liu","year":"2019","unstructured":"Liu J, Liang WN, Jing W, et al. Countdown to 2030: eliminating hepatitis B disease, China. Bull World Health Organ. 2019;97:230\u2013238","journal-title":"Bull World Health Organ"},{"key":"10400_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2471\/BLT.14.139626","volume":"93","author":"AL Wang","year":"2015","unstructured":"Wang AL, Qiao YP, Wang LH, et al. Integrated prevention of mother-to-child transmission for human immunodeficiency virus, syphilis and hepatitis B virus in China. Bull World Health Organ. 2015;93:52\u201356","journal-title":"Bull World Health Organ"},{"key":"10400_CR19","unstructured":"WHO. Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy. Jul 27, 2020. https:\/\/www.who.int\/publications\/i\/item\/978-92-4-000270-8. Accessed May 18, 2021."},{"issue":"6","key":"10400_CR20","first-page":"878","volume":"33","author":"WW Li","year":"2017","unstructured":"Li WW, Cai YM, Cai Q, et al. Utilization of data from children immunization information system: a review. Chin J Public Health. 2017;33(6):878\u2013882","journal-title":"Chin J Public Health"},{"key":"10400_CR21","unstructured":"National Health Commission of People's Republic of China. Immunization Schedules and Instructions of National Immunization Program for Children (2021 version). Mar 12, 2021.http:\/\/www.nhc.gov.cn\/jkj\/s3581\/202103\/590a8c7915054aa682a8d2ae8199e222.shtml. Accessed May 8, 2021."},{"key":"10400_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12072-018-9863-0","volume":"12","author":"CL Lin","year":"2018","unstructured":"Lin CL, Kao JH. Prevention of mother-to-child transmission: the key of hepatitis B virus elimination. Hepatol Int. 2018;12:94\u201396","journal-title":"Hepatol Int"},{"key":"10400_CR23","first-page":"711","volume":"37","author":"Chinese Society of Infectious Diseases; Hepatology Society of Chinese Medical Association","year":"2019","unstructured":"Chinese Society of Infectious Diseases; Hepatology Society of Chinese Medical Association. Guidelines for chronic hepatitis B prevention and treatment (2019 edition). Chin J Inf Dis. 2019;37:711\u201336","journal-title":"Chin J Inf Dis"},{"key":"10400_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015092","volume":"98","author":"J Zeng","year":"2019","unstructured":"Zeng J, Zheng C, Li H. Effectiveness of tenofovir or telbivudine in preventing HBV vertical transmission for pregnancy. Medicine (Baltimore). 2019;98: e15092","journal-title":"Medicine (Baltimore)"},{"key":"10400_CR25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/jvh.13036","volume":"26","author":"J Song","year":"2019","unstructured":"Song J, Yang F, Wang S, et al. Efficacy and safety of antiviral treatment on blocking the mother-to-child transmission of hepatitis B virus: a meta-analysis. J Viral Hepat. 2019;26:397\u2013406","journal-title":"J Viral Hepat"},{"key":"10400_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/apt.15064","volume":"49","author":"M Wang","year":"2019","unstructured":"Wang M, Bian Q, Zhu Y, et al. Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load. Aliment Pharmacol Ther. 2019;49:211\u2013217","journal-title":"Aliment Pharmacol Ther"},{"key":"10400_CR27","doi-asserted-by":"publisher","first-page":"12056","DOI":"10.3748\/wjg.v20.i34.12056","volume":"20","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Chen C, Li Z, et al. Individualized management of pregnant women with high hepatitis B virus DNA levels. World J Gastroenterol. 2014;20:12056\u201312061","journal-title":"World J Gastroenterol"},{"key":"10400_CR28","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/hep.27034","volume":"60","author":"H Zhang","year":"2014","unstructured":"Zhang H, Pan CQ, Pang Q, et al. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. Hepatology. 2014;60:468\u2013476","journal-title":"Hepatology"},{"key":"10400_CR29","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.cgh.2018.10.007","volume":"17","author":"J Hou","year":"2019","unstructured":"Hou J, Cui F, Ding Y, et al. Management algorithm for interrupting mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol. 2019;17:1929-1936.e1","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10400_CR30","unstructured":"Chinese Center for Disease Control and Prevention. Technical report of post-vaccination serological testing (PVST) of HBV-exposed newborns in China (Phase one). 2018."},{"key":"10400_CR31","volume-title":"Investigation on the willingness of HBsAg positive mothers for their children participating in PVST and analysis of the PVST results in six provinces in China","author":"LL Xv","year":"2020","unstructured":"Xv LL. Investigation on the willingness of HBsAg positive mothers for their children participating in PVST and analysis of the PVST results in six provinces in China. Beijing: Chinese Center for Disease Control and Prevention; 2020"},{"key":"10400_CR32","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.15585\/mmwr.mm6439a6","volume":"64","author":"S Schillie","year":"2015","unstructured":"Schillie S, Murphy TV, Fenlon N, et al. Update: shortened interval for postvaccination serologic testing of infants born to hepatitis B-infected mothers. MMWR Morb Mortal Wkly Rep. 2015;64:1118\u20131120","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10400_CR33","first-page":"1","volume":"54","author":"Advisory Committee on Immunization Practices (ACIP)","year":"2005","unstructured":"Advisory Committee on Immunization Practices (ACIP). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005;54:1\u201331","journal-title":"MMWR Recomm Rep"},{"key":"10400_CR34","unstructured":"WHO. Guidelines on hepatitis B and C testing. Feb 16, 2017. https:\/\/www.who.int\/publications\/i\/item\/9789241549981. Accessed Jan 30, 2021."},{"key":"10400_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40249-019-0568-y","volume":"8","author":"H Zheng","year":"2019","unstructured":"Zheng H, Zhang GM, Chan PL, et al. Compliance among infants exposed to hepatitis B virus in a post-vaccination serological testing program in four provinces in China. Infect Dis Poverty. 2019;8:57","journal-title":"Infect Dis Poverty"},{"key":"10400_CR36","unstructured":"Department of Maternal and Child Health, National Health Commission of People\u2019s Republic of China. Guidelines for the prevention of mother-to-child transmission of HIV, syphilis and hepatitis B (2020 edition). Nov 25, 2020. http:\/\/www.nhc.gov.cn\/fys\/s3581\/202011\/fc7b46b2b48b45a69bd390ae3a62d065.shtml. Accessed Feb 18, 2021."},{"key":"10400_CR37","unstructured":"WHO. Guidelines on hepatitis B and C testing. Geneva: World Health Organization; 2017. https:\/\/www.afro.who.int\/publications\/guidelines-hepatitis-b-and-c-testing"},{"key":"10400_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2471\/BLT.19.248146","volume":"99","author":"Z Hui","year":"2021","unstructured":"Hui Z, Nayagam S, Chan P, et al. Progress towards elimination of mother-to-child transmission of hepatitis B virus infection in China: a modelling analysis. Bull World Health Organ. 2021;99:10\u201318","journal-title":"Bull World Health Organ"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10400-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10400-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10400-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:02:23Z","timestamp":1744207343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10400-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,18]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10400"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10400-0","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,18]]},"assertion":[{"value":"21 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Hui Zheng, Nick Walsh, Olufunmilayo Lesi and Fuqiang Cui have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}